Company news
New role will boost strategy for scalable solutions
Feb 15 2024
TTP Company Cellular Origins has appointed Peter Crossley as Chief Operating Officer (COO), to bolster Cellular Origins’ mission to develop scalable automation solutions for cell therapy manufacture. Bringing 27 years’ experience in novel technology and product development to this key role, he will be responsible for driving team growth and overseeing people development at the company.
Having worked as a Consultant at TTP for the past 17 years, he was most recently interim CTO at Depixus. With a BEng in Aerospace Engineering from the University of Bristol, Peter began his career in gas turbine development at Rolls-Royce, before moving to R&D and technical management in consumer products at Dyson and Fisher & Paykel.
“Cellular Origins is in an exciting phase of growth. As COO, I look forward to driving the expansion of Cellular Origins’ world-class team, as well as supporting them to bring about a revolution in cell therapy manufacture that will deliver these life changing treatments to all who need them.”
Dr Edwin Stone, CEO at Cellular Origins, added: “I am delighted to welcome Peter. His proven cross-sector experience, leadership skills and ability to turn ground-breaking innovation into commercial reality, will accelerate our mission to develop scalable automation solutions for cell therapies.”
More information online
Digital Edition
ILM 50.2 March 2025
March 2025
Chromatography Articles - Effects of small deviations in flow rate on GPC/SEC results Mass Spectrometry & Spectroscopy Articles - Waiting for the present to catch up to the future: A bette...
View all digital editions
Events
Mar 31 2025 Beijing, China
Microbiology Society Annual Conference 2025
Mar 31 2025 Liverpool, UK
Apr 01 2025 New York, USA
Apr 02 2025 Saigon, Vietnam
Apr 09 2025 Tokyo, Japan